Intellective Biologics (Suzhou) Co., Ltd.

Biologics CDMO developing and manufacturing antibodies, antibody-drug conjugates, fusion proteins and recombinant proteins under contract. It reports production scales from one to 210,000 litres and having passed one hundred thousand litres of installed capacity in 2025. It operates three cGMP plants in Suzhou, with European QP certification obtained between 2020 and 2023.